Case number 1:22-cv-01061
Neurocrine Biosciences, Inc. v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 18, 2022 | 13 | SO ORDERED re (12 in 1:22-cv-00639-MN, 12 in 1:22-cv-01061-MN) Stipulation and Order Regarding Case Consolidation. Signed by Judge Maryellen Noreika on 11/18/2022. (dlw) (Entered: 11/18/2022) (3) |
| Nov 17, 2022 | 12 | STIPULATION Regarding Consolidation, Case Schedule, and Protective Order, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/17/2022) (3) |
| Nov 10, 2022 | 11 | STIPULATION Seeking to Extend the Deadline by Which the Parties in the Non-Consolidated Cases Must Inform the Court Whether they Agree to be Consolidated With, and Adopt the Schedule of the Lead Case, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/10/2022) (5) |
| Oct 19, 2022 | 10 | ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 10/24/2022 teleconference is RESET for 11/3/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/19/2022. (dlw) (Entered: 10/19/2022) (0) |
| Oct 14, 2022 | 9 | NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-41) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/14/2022) (4) |
| Oct 6, 2022 | 8 | ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw) (Entered: 10/06/2022) (0) |
| Sep 30, 2022 | 7 | ANSWER to 6 Answer to Complaint, Counterclaim by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 09/30/2022) (7) |
| Sep 9, 2022 | 6 | ANSWER to 1 Complaint, , COUNTERCLAIM against Neurocrine Biosciences, Inc. by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 09/09/2022) (27) |
| Aug 11, 2022 | 1 | Complaint* (1) |
| Aug 11, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) (Entered: 08/12/2022) (3) |
| Aug 11, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2022. Date of Expiration of Patent: 9/18/2038.Thirty Month Stay Deadline: 10/11/2024. (lam) (Entered: 08/12/2022) (2) |
| Aug 11, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,311,532. (lam) (Entered: 08/12/2022) (1) |
| Aug 11, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (lam) (Entered: 08/12/2022) (1) |
